Physician profile
Austin Hill
NPI 1518209451
$5,077.72
in general payments reported to CMS, 2019-2025
16 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $88.55 · 2021: $979 · 2022: $744 · 2023: $2,190 · 2024: $434 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,039 · Travel and Lodging: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,038.92 |
| Travel and Lodging | $837.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,571.43 | 2019-2025 | Solyx Sis System, Obtryx System - Curved, Axonics |
| Axonics, INC. | $1,167.21 | 2021-2024 | Axonics, Bulkamid |
| Coloplast Corp | $442.14 | 2021-2023 | Altis, Restorelle |
| Medtronic, INC. | $418.68 | 2021-2025 | Interstim, Altaviva |
| Femselect INC. | $354.27 | 2023 | Enplace |
| Medtronic USA, INC. | $249.61 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $226.10 | 2023-2025 | Gemtesa |
| Caldera Medical, INC | $206.07 | 2021-2025 | |
| Astellas Pharma US INC | $137.50 | 2021-2024 | Veozah, Myrbetriq |
| Urovant Sciences INC | $102.62 | 2021-2022 | |
| Abbvie INC. | $77.54 | 2023-2025 | |
| Davol INC. | $42.47 | 2023 | Arista Ah Flexitip |
| Becton, Dickinson and Company | $25.11 | 2024 | Bd Max System, Bd Max Instrument |
| Olympus America INC. | $20.09 | 2023 | Olympus |
| Laborie Medical Technologies Corp. | $19.24 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $17.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.